2020 Sponsors

Thank you for attending the 2020 Annual Meeting of INFORM!

On Demand Viewing of the 2020 INFORM Symposium is now available Through April of 2021!

If you have not registered for INFORM 2020 and would like to view the symposium in its entirety, please use the link below to register.

For NEW registrations there will be a $50 USD registration fee.

For New Registration Click Here

Registration includes:

All lectures with Q&A that followed during the live event

Panel Discussions at the end of each day

Access to the Exhibition Hall to view Sponsor Booths

Access to the Poster Hall and all Posters

The Event Program which includes all the submitted Abstracts

Six-month access to the site to visit as often as you would like!

If you have already registered for the symposium click below.

I Have Already Registered

Ultragenyx Announces U.S. FDA Approval of Dojolvi™ (UX007/triheptanoin),
the First FDA-Approved Therapy
for the Treatment of Long-chain Fatty Acid Oxidation Disorders

READ MORE

INFORM Network

The International Network for Fatty Acid Oxidation Research and Management (INFORM) was formed by Jerry Vockley in order to promote research and discussion into the cause, diagnosis, and management of fatty acid oxidation disorders (FAODs). We offer several learning opportunities throughout the year for patients, families, and researchers. Our network will provide ​a collaborative framework for ongoing communication and research regarding these disorders, as well as work with our partners to sponsor a meeting each year. Please plan to join us in the future to hear from the experts on a wide range of topics from molecular pathophysiology to treatment strategies.

Virtual Tissue Bank

The Virtual Tissue Bank (VTB) grew out of the desire to share research sample information and testing results to help advance the diagnosis and treatment of fatty oxidation disorders and the carnitine cycle in order to increase knowledge and help patients worldwide.

INFORM Families

At INFORM Network, we offer a comprehensive resource for families and friends impacted by fatty acid oxidation disorders. Here you can learn the latest developments in genetic research and access important information on screening, diagnosis, and treatment.

Do you reside in Canada and are living with or caring for someone living with a LC-FAOD ?

Ultragenyx Pharmaceutical Inc. is planning a virtual Patient and Caregiver Advisory Board, click here for more information.

Check Back Soon for Upcoming
Research Webinars

Watch Previous Webinars Below

(To view presentations, click image below)

4/13/2020

Assessment of the Efficacy of Medium/Branched Chain Fatty Acids in Treating FAODs using Patient Fibroblasts

4/7/2020

Mito Matters Q&A with Dr. Jerry Vockley, MD, PhD

​Join us for a Q & A with Dr. Jerry Vockley (UPMC, INFORM) to discuss the impact of Covid-19 for Fatty Acid Oxidation Disorders.

12/16/2019

Emerging Therapies for Phenylketonuria

Join Jerry Vockley, MD, PhD, director of the Center for Rare Disease Therapy and chief, Medical Genetics, at UPMC Children’s Hospital of Pittsburgh for a free webinar. Dr. Vockley will discuss emerging therapies for PKU or phenylketonuria, an inborn error of protein metabolism. The presentation is designed for patients, parents, guardians, and caregivers and will be followed by a live question and answer session.

10/4/2019

Monthly Mito: Expert Series

​Dr. Jerry Vockey, MD, PhD, University of Pittsburgh Children’s Hospital,
International Network for Fatty Acid Oxidation Research and Management (INFORM)

6/17/2019

The Fate of Medium-Chain Fatty Acids in Very Long-Chain Acyl-CoA Dehydrogenase Deficient (VCLADD): A Matter of Sex?

Zeinab Wehbe, PhD Student, Department of General Pediatrics and Adolescent Medicine
Laboratory of Clinical Biochemistry and Metabolism
Medical Center – University of Freiburg
Faculty of Medicine, University of Freiburg

Vockely Webinar- Novel Therapies for Fatty Acid Oxidation Disorders

2/5/2019

Novel Therapies for Fatty Acid Oxidation Disorders
by Jerry Vockley, MD, PhD

5/21/2018

Enhancing Expression and Chaperoning Unstable Proteins:
Getting closer to effective therapy for fatty acid b-oxidation disorders

​Al-Walid Mohsen, PhD Research Associate Professor of Pediatrics Medical Genetics,
Children’s Hospital of Pittsburgh / University of Pittsburgh.

4/23/2018

Loss of Retinal Pigment Epithelium: The Initial Event in LCHAD Retinopathy Progression?

Melanie Gillingham, PhD, RD / Associate Professor /Department of Molecular and Medical Genetics
Graduate Programs in Human Nutrition / Oregon Health & Science University

Modeling LCHAD Retinopathy in a Patient Derived Retinal Pigment Epithelium


Tiffany DeVine, PhD / Postdoctoral researcher /Department of
Molecular and Medical Genetics
Oregon Health & Science University

Approximately

0
Infants are Identified yearly with FAOD’s in the United States through Newborn Screening
0
People Identified in the United States with FAOD’s
0
People Living in the World with FAOD’s

“I appreciate that INFORM always provides us the most advanced, the most professional, and the most comprehensive information about defects of beta-oxidation.”

TOSHIYUKI FUKAO, PROFESSOR, GIFU UNIVERSITY, JAPAN

“Together we can generate the energy to beat these diseases”

JERRY VOCKLEY, MD, PhD , INFORM, SCIENTIFIC ORGANIZER

“INFORM brings together the best and brightest researchers and physicians from around the world to discuss cutting edge research and best and new practices in fatty acid oxidation disorders.”

KEITH W. MCINTIRE, DEPARTMENT OF GENETICS COORDINATOR

“The challenge with being on the cutting edge is that you are always dealing with things that didn’t happen yesterday”.

JERRY VOCKLEY, MD, PhD , INFORM, SCIENTIFIC ORGANIZER

2020 Sponsors

Special thanks to our 2020 Sponsors!
With significant new research and best practices on the horizon,
INFORM 2020 has been our most informative meeting ever!

View now On Demand!

New Registration
Previously Registered

Unlocking the Future

We are committed to discovering new FAOD treatments and cures to improve the lives of our patients and their families.

Contact Us